Tedor Pharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Tedor Pharma

Access the complete profile.

Tedor Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	400 Highland Corporate Drive Cumberland, RI 02864

Note: Revenues for privately held companies are statistical evaluations.


Tedor Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tedor Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Tedor Pharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Tedor Pharma Annual Revenue and Growth Rate

Tedor Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Tedor Pharma's revenues are gauged from an analysis of company filings.

Tedor Pharma's Income Statement (based on Industry Averages)

Tedor Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Tedor Pharma is developing and marketing. Tedor Pharma doesn't have any recent trademark applications, indicating Tedor Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
POLYDOSE Scientific services, namely, scientific research and development, chemical research and development, and pharmaceutical research and development services relating to chemical and pharmaceutical preparations	02/12/2007
T Pharmaceutical products for use in treating patients suffering from pulmonary disorders such as asthma, bile-related disorders and conditions, dermatological conditions such as acne, and obesity	06/12/2001
TEDOR PHARMA Pharmaceutical products for use in treating patients suffering from pulmonary disorders such as asthma, bile-related disorders and conditions, dermatological conditions such as acne, and obesity	06/12/2001

See all trademarks and details in the Full Report.

Market Share of Tedor Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tedor Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Tedor Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DENISON PHARMACEUTICALS	Lincoln, RI	100
WEXFORD LABORATORIES	Warwick, RI	5
TEDOR PHARMA	Cumberland, RI	5
PURE MARROW	Barrington, RI	0

Future Competition: Tedor Pharma's Fastest Growing Competitors

These companies are in the same general field as Tedor Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)